share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Atkinson Edward Morrow III

SEC announcement ·  Jun 14 04:15
Summary by Futu AI
Edward Morrow III, EVP and Chief Technical Operations Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 14,112 shares of common stock over two consecutive days. On June 11, 2024, Morrow disposed of 6,824 shares at a price of $481.96 per share, followed by the sale of 7,288 shares on June 12, 2024, at $478.00 per share. The transactions resulted in a total market value of $6,772,559.04. Following these sales, Morrow directly holds 15,972 shares of Vertex Pharmaceuticals.
Edward Morrow III, EVP and Chief Technical Operations Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 14,112 shares of common stock over two consecutive days. On June 11, 2024, Morrow disposed of 6,824 shares at a price of $481.96 per share, followed by the sale of 7,288 shares on June 12, 2024, at $478.00 per share. The transactions resulted in a total market value of $6,772,559.04. Following these sales, Morrow directly holds 15,972 shares of Vertex Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.